Search Prime Grants

R01CA033193

Project Grant

Overview

Grant Description
IARC MONOGRAPHS ON THE IDENTIFICATION OF CARCINOGENIC HAZARDS TO HUMANS - PROJECT SUMMARY/ABSTRACT SINCE 1971, THE IARC MONOGRAPHS ON THE IDENTIFICATION OF CARCINOGENIC HAZARDS TO HUMANS HAS PROVIDED AN EVIDENCE-BASED APPROACH TO IDENTIFYING THE PREVENTABLE CAUSES OF HUMAN CANCER. ORGANIZATIONS WORLDWIDE RELY ON THE IARC MONOGRAPHS AS A TRUSTWORTHY SOURCE OF CARCINOGENICITY EVALUATIONS IN THEIR EFFORTS TO CONTROL CANCER. AGENTS EVALUATED BY THE MONOGRAPHS ENCOMPASS CHEMICALS, PHYSICAL AND BIOLOGICAL AGENTS, COMPLEX MIXTURES, OCCUPATIONAL EXPOSURE CIRCUMSTANCES, AND OTHER EXPOSURES OF EVERYDAY LIFE. TO DATE, 1021 AGENTS HAVE BEEN EVALUATED, WITH 121 CLASSIFIED AS “CARCINOGENIC”, 89 AS “PROBABLY CARCINOGENIC”, AND 315 AS “POSSIBLY CARCINOGENIC” TO HUMANS. AGENTS ARE SELECTED FOR EVALUATION BASED ON EVIDENCE OF HUMAN EXPOSURE AND OF CARCINOGENICITY, AND PUBLIC HEALTH IMPORTANCE. MONOGRAPHS ARE DEVELOPED BY INDEPENDENT GLOBAL EXPERTS WITHOUT CONFLICTS OF INTEREST. EACH MONOGRAPH INCLUDES SYSTEMATIC REVIEWS OF THE PERTINENT SCIENTIFIC LITERATURE COVERING THREE UNIQUE STREAMS OF EVIDENCE (CANCER IN HUMANS, CANCER IN EXPERIMENTAL ANIMALS, AND MECHANISTIC EVIDENCE). THE
Awardee
Centre International De Recherche Sur Le Cancer
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
93.393 - Cancer Cause and Prevention Research
Awarding / Funding Agency
National Cancer Institute (NCI) [HHS - NIH]
Place of Performance
France
Geographic Scope
Foreign
Related Opportunity
Limited Competition: International Agency for Research on Cancer (IARC) Monographs Program (R01 Clinical Trial Not Allowed) (RFA-CA-20-045)
Analysis Notes
Amendment Since initial award the total obligations have increased 342% from $880,253 to $3,887,961.
Centre International De Recherche Sur Le Cancer was awarded Carcinogenic Hazards Identification: IARC Monographs Project Project Grant R01CA033193 worth $3,887,961 from National Cancer Institute in September 1985 with work to be completed primarily in France. The grant has a duration of 41 years and was awarded through assistance program 93.393 Cancer Cause and Prevention Research. The Project Grant was awarded through grant opportunity Limited Competition: International Agency for Research on Cancer (IARC) Monographs Program (R01 Clinical Trial Not Allowed).

Status
(Ongoing)

Last Modified 7/25/24

Period of Performance
9/1/85
Start Date
8/31/26
End Date
98.0% Complete

Funding Split
$3.9M
Federal Obligation
$0.0
Non-Federal Obligation
$3.9M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to R01CA033193

Transaction History

Modifications to R01CA033193

Additional Detail

Award ID FAIN
R01CA033193
SAI Number
R01CA033193-4204341393
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Non-Domestic (Non-U.S.) Entity
Awarding Office
75NC00 NIH NATIONAL CANCER INSTITUTE
Funding Office
75NC00 NIH NATIONAL CANCER INSTITUTE
Awardee UEI
HSMZYXZ7M358
Awardee CAGE
I9027
Performance District
Not Applicable

Budget Funding

Federal Account Budget Subfunction Object Class Total Percentage
National Cancer Institute, National Institutes of Health, Health and Human Services (075-0849) Health research and training Grants, subsidies, and contributions (41.0) $1,750,253 89%
National Institute of Environmental Health Sciences, National Institutes of Health, Health and Human Services (075-0862) Health research and training Grants, subsidies, and contributions (41.0) $216,714 11%
Modified: 7/25/24